Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

FR-127519: new CCK-A antagonist assessed in functional model

Nov. 25, 1997

NK3 antagonist demonstrates intestinal antiinflammatory activity

Nov. 24, 1997

Six-month trial of lamivudine for chronic hepatitis B

Nov. 24, 1997

Prokinetic effects described for DQ-2511, an antiulcer agent from Daiichi

Nov. 21, 1997

Effects of rPAF-AH in opossums with severe pancreatitis

Nov. 20, 1997

L-Arginine safe and effective in spastic esophageal motor disorders

Nov. 19, 1997

New laxative proves safe and effective for short-term treatment of constipation

Nov. 19, 1997

Centocor's anti-TNF-alpha antibody closes fistulae in Crohn's patients

Nov. 19, 1997

Roberts completes phase Ia trial of LY-315535

Nov. 11, 1997

Gastric prokinetic agents under development at Janssen

Nov. 7, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 2, 2026
ASCO 2026: A revolution in pancreatic cancer
BioWorld
At the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, Revolution Medicines Inc. followed up its stellar top-line data with the details from the...
BMS’ mezigdomide doubles PFS in multiple myeloma
BioWorld
Bristol Myers Squibb Co. disclosed in March 2026 that the phase III portion of the seamless phase II/III Successor-2 study testing mezigdomide in combination with...
ADCs, multispecific antibodies anchor $10B Pfizer-Innovent deal
BioWorld
Pfizer Inc. is paying Innovent Biologics Co. Ltd. $650 million up front and up to $9.85 billion in milestones, plus royalties, to collaborate across 12 early...